Thomas F. Cowhey - 30 Nov 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: SVP, Interim CFO
Signature: /s/ Thomas F. Cowhey
Issuer symbol: CVS
Transactions as of: 30 Nov 2023
Net transactions value: +$499,976
Form type: 4
Filing time: 01 Dec 2023, 17:53:05 UTC
Previous filing: 20 Oct 2023
Next filing: 01 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock (Restricted)	Award	$499,976	+7,358	+14%	$67.95	60,938	30 Nov 2023	Direct	F1
holding	CVS	Common Stock						14,977	30 Nov 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CVS	Stock Option						20,790	30 Nov 2023	Common Stock	20,790	$101.09	Direct	F2
holding	CVS	Stock Option						33,402	30 Nov 2023	Common Stock	33,402	$74.31	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse on 11/30/2026.
F2	Option became exercisable in four equal annual installments, commencing on 4/1/2023.
F3	Option becomes exercisable in four equal annual installments, commencing on 4/1/2024.